Assessment of the safety and efficacy of the novel tetrapeptide ITF-1697 on infarct size after primary PTCA in acute myocardial infarction: a randomised, placebo-controlled pilot trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples